Skip to main content
Sairah Ahmed, MD, Oncology, Houston, TX, University of Texas M.D. Anderson Cancer Center

SairahAhmedMD

Oncology Houston, TX

Physician

Are you Dr. Ahmed?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 45 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Sairah Ahmed, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Arizona, and Alabama. She is affiliated with University of Texas M.D. Anderson Cancer Center.

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2007 - 2010
  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 2003 - 2006
  • Khyber Medical College
    Khyber Medical CollegeClass of 2000

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • OK State Medical License
    OK State Medical License 2020 - 2025
  • TX State Medical License
    TX State Medical License 2011 - 2025
  • AZ State Medical License
    AZ State Medical License 2023 - 2024
  • AL State Medical License
    AL State Medical License 2023 - 2024
  • TN State Medical License
    TN State Medical License 2023 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • What Are the New Weight Loss Drugs Everyone Is Talking About & What’s the Connection Between Weight and Cancer?
    What Are the New Weight Loss Drugs Everyone Is Talking About & What’s the Connection Between Weight and Cancer?January 15th, 2023
  • Tessa Therapeutics Announces Updated Safety, Efficacy and Biomarker Data from Phase 2 Trial of Autologous CD30.CAR-T Therapy (TT11) in Relapsed or Refractory Classical Hodgkin Lymphoma
    Tessa Therapeutics Announces Updated Safety, Efficacy and Biomarker Data from Phase 2 Trial of Autologous CD30.CAR-T Therapy (TT11) in Relapsed or Refractory Classical Hodgkin LymphomaDecember 13th, 2022
  • CAR T Cell Therapy Put Me into Complete Remission After a Non-Hodgkin Lymphoma Diagnosis
    CAR T Cell Therapy Put Me into Complete Remission After a Non-Hodgkin Lymphoma DiagnosisSeptember 26th, 2022
  • Join now to see all

Hospital Affiliations